Webinar
The Fastest Kinetic Screening Available for Your Antibody Discovery – April 9, 2020
Webinar
Speed up Your Antibody Discovery with Massive Epitope Binning – April 2, 2020
Webinar
The Therapeutic Antibody Screening Revolution in the Post Genomics Era – November 21, 2019
Webinar
Therapeutic Antibody Discovery Process Using High Throughput SPR
Webinar
Characterization of Ion Channel Activity Blocking mAbs with High Throughput SPR – April 24, 2018
Learn how Tetragenetics has developed a strategy to generate and identify monoclonal antibodies targeting ion channels based on high-level expression of recombinant channels in Tetrahymena thermophila, enabling the development of potent immunogens and tools that allow deep mining of the immune repertoire.
Carterra’s LSA can analyze up to 384 binding interactions simultaneously, providing mAb characterization throughput to match the output of the current generation of mAb expression platforms; all antibodies can be rapidly and comprehensively screened so that unique epitopes and potential novel therapeutic candidates are not missed, while expanding IP coverage.
Speakers:
Paul Colussi, PhD, Vice President, Research, TetraGenetics
Yasmina Noubia Abdiche, PhD, Chief Scientific Officer, Carterra
Webinar
Accelerating Antibody Screening with Array-Based Surface Plasmon Resonance – January 17, 2018
We present case studies highlighting our “No Compromise Kinetics™” screening of antigens over large mAb panels in a capture format, as well as a comprehensive epitope-binning analysis on a single 384-mAb array. Results from these analyses, along with a discussion of current SPR array methodologies, will likely streamline your mAb characterization workflows significantly.
Speakers:
Kathryn Ching, PhD, Senior Scientist, Ligand Pharmaceuticals
Yasmina Noubia Abdiche, PhD, Chief Scientific Officer, Carterra
Webinar
Accelerate Your Antibody Discovery with High-Throughput Kinetic Screening of Phage Libraries – November 9, 2017
Distributed Bio’s phage display library has been computationally optimized based on the analysis of thousands of human antibody repertoires. Their library routinely produces over 5000 unique antibodies against any target.
How do they efficiently screen so many unique hits? They use the Carterra platform.
Speakers:
Jacob Glanville, PhD, Chief Scientific Officer, Distributed Bio
Yasmina Noubia Abdiche, PhD, Chief Scientific Officer, Carterra